Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.28 (
chloramphenicol acetyltransferase
)
5,100
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Nucleotide sequence analysis of six independently isolated cDNAs for rat
acyl-CoA synthetase
(
ACS
) revealed three forms of
ACS
mRNA, designated form-A, -B, and -C mRNAs, which differ in their 5'-untranslated regions. Form-A mRNA was preferentially detected in normal and peroxisome-induced livers, whereas form-B mRNA was found in peroxisome-induced livers but not in normal livers and hearts, and form-C mRNA was preferentially found in normal hearts and peroxisome-induced livers. Analysis of two overlapping genomic clones for the rat
ACS
gene revealed that the three 5'-untranslated regions of the mRNAs are individually encoded by three different exons located within a 20-kilobase genomic fragment. The transcription start sites of the three forms of
ACS
mRNA were determined and nucleotide sequences of 5'-upstream regions of the three 5'-end exons were determined. The 5'-upstream regions were fused to the
chloramphenicol acetyltransferase
gene and transcription units of the three forms of
ACS
mRNAs were determined. These data indicate that the three forms of
ACS
mRNA with 5'-end heterogeneity are generated by alternative transcription from three promoters in the rat
ACS
gene.
...
PMID:Multiple promoters in rat acyl-CoA synthetase gene mediate differential expression of multiple transcripts with 5'-end heterogeneity. 772